Anti-idiotype X anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4736-4743

  Avin, Esther ^a   Haimovich, Joseph ^a   Hollander, Nurit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CD44 ANTIBODY; CELL ADHESION MOLECULE; HERMES ANTIGEN; HYALURONIC ACID; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BINDING AFFINITY; BONE MARROW; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; LYMPH NODE; LYMPHOID ORGAN; LYMPHOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SPLEEN;

EID: 4644245913     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4736     Document Type: Article

References (52)

1. Roos, E. 1993. Adhesion molecules in lymphoma metastasis. Semin. Cancer Biol. 4:285.
2. Naor, D., R. Vogt Sionov, M. Zahalka, M. Rochman, B. Holzmann., and D. Ish-Shalom. 1998. Organ-specific requirements for cell adhesion molecules during lymphoma cell dissemination. Curr. Top. Microbiol. Immunol. 231:143.
3. Drillenburg, P., and S. T. Pals. 2000. Cell adhesion in lymphoma dissemination. Blood 95:1900.
4. Aoudjit, F., E. F. Potworowski, T. A. Springer, and Y. St-Pierre. 1998. Protection from lymphoma cell metastasis in ICAM-1 mutant mice: a posthoming event. J. Immunol. 161:2333.
5. Zahalka, M. A., E. Okon, U. Gosslar, B. Holzmann, and D. Naor. 1995. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol. 154:5345.
6. 3 in cell adhesion, motility, and liver metastasis of murine RAWI17 large cell lymphoma. Cancer Res. 56:3103.
7. Rocha, M., A. Kruger, V. Umansky, P. von Hoegen, D. Naor, and V. Schirrmacher. 1996. Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis. Clin. Cancer Res. 2:811.
8. Harning, R., C. Myers, and V. J. Merluzzi. 1993. Monoclonal antibodies to lymphocyte function-associated antigen-1 inhibit invasion of human lymphoma and metastasis of murine lymphoma. Clin. Exp. Metastasis 11:337.
9. Scheynius, A., R. L. Camp, and E. Pure. 1993. Reduced contact sensitivity in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150:655.
10. Camp, R. L., A. Scheynius, C. Johansson, and E. Pure. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497.
11. Lepault, F., M. C. Gagnerault, C. Faveeuw, and C. Boitard. 1994. Recirculation, phenotype, and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur. J. Immunol. 24:3106.
12. Wong, J. T., and R. B. Colvin. 1987. Bi-specific antibodies: selective binding and complement fixation to cells that express two different surface antigens. J. Immunol. 139:1369.
13. + T cells. J. Immunol. 149:1840.
14. Kollet, O., I. Haimovich, and N. Hollander. 1998. Idiotype-specific inhibition of LFA-1-mediated cell adhesion by anti-idiotype X anti-LFA-1 bispecific antibodies. Immunol. Lett. 62:171.
15. Hurwitz, E., D, Burowski, R. Kashi, N. Hollander and J. Haimovich. 1986. A synergistic effect between anti-idiotype antibodies and anti-neoplastic drugs in the therapy of a murine B-cell tumor. Int. J. Cancer 37:739.
16. Campbell, M. J., L. Esserman, N. E. Byers, A. C. Allison, and R. Levy. 1990. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145:1029.
17. Kwak, L. W., H. A. Young, R. W. Pennington, and S. D. Weeks. 1996. Vaccination with syngeneic lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc. Natl. Acad. Sci. USA 93:10972.
18. Haimovich, J., T. Kukulansky, B. Weissman, and N. Hollander. 1999. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice. Cancer Immunol. Immunother. 47:330.
19. Cohen, S., J. Haimovich, and N. Hollander. 2003. Anti-idiotype X anti-LFA-1 bispecific antibodies inhibit metastasis of B cell lymphoma. J. Immunol. 170:2695.
20. Sy, M. S., Y. J. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859.
21. Sy, M. S., Y. S. Guo, and I. Stamenkovic. 1992. Inhibition of tumor growth in vivo with soluble CD44-immunoglobulin fusion protein. J. Exp. Med. 176:623.
22. Guo, Y., J. Ma, J. Wang, X. Che, J. Narula, M. Bigby, M. Wu, and M. S. Sy. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561.
23. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53.
24. Aziz, K. A., K. J. Till, M. Zuzel, and J. C. Cawley. 2000. Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronection synthesis in hairy cell leukemia. Blood 96:3161.
25. Ahrens, T., J. P. Sleeman, C. M. Schempp, N. Howells, M. Hofmann, H. Ponta, P. Herrlich, and J. C. Simon. 2001. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 20:3399.
26. Hori, T., Y. Yamashita, M. Ohira, Y. Matsumura, K. Muguruma, and K. Hirakawa. 2001. A novel orthotopic implantation model of human esophageal carcinoma in nude rats: CD44H mediates cancer cell invasion. Int. J. Cancer 92:489.
27. Bergman, Y., and J. Haimovich. 1977. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur. J. Immunol. 7:413.
28. Taya, M., and J. Haimovich. 1991. Immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumour cells appearing a long time after the initial tumour inoculation. Cancer Immunol. Immunother. 34:43.
29. Maloney, D. G., M. S. Kaminski, D. Burowski, J. Haimovich, and R. Levy. 1985. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4:191.
30. Aviram, R., N. Raz, T. Kukulansky, and. N. Hollander. 2001. Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma. Cancer Immunol. Immunother. 50:61.
31. Myake, K., K. L. Medina, S. Hayashi, S. Ono, T. Hamaoka, and P. W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lymph-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477.
32. Brown, S. L., R. A. Miller, S. J. Horning, D. Czerwinski, S. M. Hart, R. McElderry, T. Basham, R. A. Warnke, T. C. Merigan, and R. Levy. 1989. Treatment of B-cell lymphoma with anti-idiotype antibodies alone and in combination with α interferon. Blood 73:651.
33. DeGrendele, H. C., P. Estess, and M. H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672.
34. De Gast, G. C., J. G. van de Winkel, and B. E. Bast. 1997. Clinical perspectives of bispecific antibodies in cancer. Cancer Immunol. Immunother. 45:121.
35. Segal, D. M., G. J. Weiner, and L. M. Weiner. 1999. Bispecific antibodies in cancer therapy. Curr. Opin. Immunol. 11:558.
36. Pals, S. T., E. Horst, G. J. Ossekoppele, C. G. Figdor, R. J. Scheper, and C. J. Meijer. 1989. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 73:885.
37. Horst, E., C. J. Meijer, T. Radaszkiewicz, G. J. Ossekoppele, J. H. Van Krieken, and S. T. Pals. 1990. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595.
38. Jalkanen, S., H. Joensuu, K. O. Soderstrom, and P. Klemi. 1991. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87:1835.
39. Mummert, M. E., D. I. Nummert, L. Ellinger, and A. Takashima. 2003. Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol. Cancer Ther. 2:295.
40. Clark, M., L. Gilliland, and H. Waldman. 1988. Hybrid antibodies for therapy. Prog. Allergy 45:31.
41. Songsivilai, S., and P. J. Lachman. 1990. Bispecific antibody: a tool for diagnosis and treatment of disease. Clin. Exp. Immunol. 79:315.
42. Lindhofer, H., R. Mocikat, B. Steipe, and S. Thierfelder. 1995. Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas: implications for a single-step purification of bispecific Abs. J. Immunol. 155:219.
43. Jonas, P., B. Holzmann, D. Jablonski-Westrch, and A. Hamann. 1998. Dissemination capacity of murine lymphoma cells is not dependent on efficient homing. Int. J. Cancer. 77:402.
44. Hamann, A., and H. G. Thiele. 1989. Molecules and regulation in lymphocyte migration. Immunol. Rev. 108:19.
45. Berlin-Rufenach, C., F. Otto, M. Mathies, J. Westermann, M. J. Owen, A. Hamann, and N. Hogg. 1999. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J. Exp. Med. 189:1467.
46. Nolte, M. A., A. Hamann, A. G. Kraal, and R. E. Mebius. 2002. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106:299.
47. Roossien, F. F., D. de Rijk, A. Bikker, and E. Roos. 1989. Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. J. Cell Biol. 108:1979.
48. + lymphoma cells in lymphoid organs. Int. J. Cancer 71:462.
49. Lo, C. G., T. T. Lu, and J. G. Cyster. 2003. Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 197:353.
50. 2-integrins and selectins. Blood 98:2403.
51. 7): a functional role in Peyer's patch-specific lymphocyte homing. Proc. Natl. Acad. Sci. USA 89:8254.
52. 4-integrins for distinct steps of lymphoma metastasis. Proc. Natl. Acad. Sci. USA 93:4821.